Skip to main content
SpringerLink
Log in

Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dannoui E, Lortholary O, Dromer F (2004) In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus. Antimicrob Agents Chemother 48:970–978

    Article  CAS  Google Scholar 

  2. Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL, Léger P, Chastre J (2008) Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 36:1405–1411

    Article  Google Scholar 

  3. Buck ML (2003) Pharmacokinetic changes during extracorporeal membrane oxygenation. Implications for drug therapy of neonates. Clin Pharmacokinet 42:403–417

    Article  PubMed  CAS  Google Scholar 

  4. Mehta NM, Halwick DR, Dodson BL, Thompson JE, Arnold JH (2007) Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment. Intensive Care Med 33:1018–1024

    Article  PubMed  CAS  Google Scholar 

  5. Pascual A, Calandra T, Bolay S, Buclin T, Bill J, Marchetti O (2008) Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis 46:201–211

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Réanimation Médicale et des Maladies Infectieuses, Hôpital Bichat–Claude Bernard, Assistance Publique-Hôpitaux de Paris, 46, rue Henri-Huchard, 75877, Paris Cedex 18, France

    Stéphanie Ruiz, Daniel Da Silva, Michel Wolff & Lila Bouadma

  2. Pharmacie Clinique, Hôpital Bichat–Claude Bernard, Assistance Publique-Hôpitaux de Paris, 46, rue Henri-Huchard, 75877, Paris Cedex 18, France

    Emmanuelle Papy & Laurent Massias

  3. Service de Chirurgie Cardiaque, Hôpital Bichat–Claude Bernard, Assistance Publique-Hôpitaux de Paris, 46, rue Henri-Huchard, 75877, Paris Cedex 18, France

    Patrick Nataf

Authors
  1. Stéphanie Ruiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emmanuelle Papy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniel Da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrick Nataf
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Laurent Massias
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michel Wolff
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lila Bouadma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michel Wolff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruiz, S., Papy, E., Da Silva, D. et al. Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation. Intensive Care Med 35, 183–184 (2009). https://doi.org/10.1007/s00134-008-1269-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-008-1269-3

Keywords

Search

Navigation